These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12071479)

  • 1. Introduction to and update of "cost effectiveness in new technology in cervix cancer screening".
    Robinowitz M
    Epidemiology; 2002 May; 13 Suppl 3():S23-5. PubMed ID: 12071479
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost effectiveness in new technology in cervix cancer screening.
    Sedlacek TV
    Epidemiology; 2002 May; 13 Suppl 3():S26-9. PubMed ID: 12071480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statement on technical devices for innovation in cervical cytology screening.
    Am J Clin Pathol; 1996 Oct; 106(4):441. PubMed ID: 8853029
    [No Abstract]   [Full Text] [Related]  

  • 4. Monolayer slide preparation and automated slide reading systems for cervical cancer screening--clinical-effectiveness analysis.
    Tecnologica MAP Suppl; 1998 Feb; ():34-9. PubMed ID: 10183359
    [No Abstract]   [Full Text] [Related]  

  • 5. A decade has passed...the Pap smear and cervical cancer.
    Linder J
    Am J Clin Pathol; 1997 Nov; 108(5):492-8. PubMed ID: 9353086
    [No Abstract]   [Full Text] [Related]  

  • 6. The ultimate goal? It depends.
    Brown E
    Physician Exec; 1996 Oct; 22(10):50-2. PubMed ID: 10162496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of three new technologies to enhance Pap testing.
    Tecnologica MAP Suppl; 1998 Feb; ():40-1. PubMed ID: 10183360
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of cervical cytology.
    McCrory DC; Matchar DB; Bastian L; Datta S; Hasselblad V; Hickey J; Myers E; Nanda K
    Evid Rep Technol Assess (Summ); 1999 Jan; (5):1-6. PubMed ID: 11925972
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased cervical cytologic smear access through increased capacity.
    Shaver JL
    J Reprod Med; 1998 Nov; 43(11):1005-6. PubMed ID: 9839272
    [No Abstract]   [Full Text] [Related]  

  • 10. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears?
    Linder J
    Cytopathology; 2002 Feb; 13(1):66. PubMed ID: 11985572
    [No Abstract]   [Full Text] [Related]  

  • 11. ASC statement on new technologies in cervical cytology screening (June 2000). American Society of Cytopathology.
    Rosenthal DL;
    Diagn Cytopathol; 2000 Dec; 23(6):430. PubMed ID: 11074653
    [No Abstract]   [Full Text] [Related]  

  • 12. An economic appraisal of a mobile cervical cytology screening service.
    Bloch B
    S Afr Med J; 1997 Feb; 87(2):231. PubMed ID: 9180819
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness and cost effectiveness of automated and semi-automated cervical screening devices: a systematic review of the literature.
    Broadstock M
    N Z Med J; 2001 Jul; 114(1135):311-3. PubMed ID: 11556445
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality control in cervical cancer screening: Brazilian experience.
    Collaço LM; de Noronha L; Bleggi-Torres LF; Pinheiro DL
    Acta Cytol; 2005; 49(6):694-6. PubMed ID: 16450916
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
    Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766
    [No Abstract]   [Full Text] [Related]  

  • 16. Liquid-based cytology in cervical screening: a rapid and systematic review.
    Payne N; Chilcott J; McGoogan E
    Health Technol Assess; 2000; 4(18):1-73. PubMed ID: 10932023
    [No Abstract]   [Full Text] [Related]  

  • 17. The current status of the Papanicolaou smear.
    Shingleton HM; Patrick RL; Johnston WW; Smith RA
    CA Cancer J Clin; 1995; 45(5):305-20. PubMed ID: 7656133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present status of cytological screening for cervix neoplasms].
    Naujoks H
    Gynakologe; 1981 Dec; 14(4):204-11. PubMed ID: 6797874
    [No Abstract]   [Full Text] [Related]  

  • 19. Does the increased sensitivity of the new Papanicolaou (Pap) tests improve the cost-effectiveness of screening for cervical cancer?
    Reust CE
    J Fam Pract; 2001 Feb; 50(2):175. PubMed ID: 11219567
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost-effectiveness of cervical screening.
    Smith WJ
    Curr Opin Obstet Gynecol; 1999 Feb; 11(1):83-5. PubMed ID: 10047969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.